Bio Fence

Company Overview

Snapshot

Founded in November 2017, Bio Fence is a startup with 1–10 employees. The company has raised $4.5 million across three funding rounds from three investors. In February 2021, Bio Fence secured an A Round of funding, led by.

Business overview

Bio Fence develops patented technology for creating antiviral and antimicrobial surfaces to combat infections spread through contaminated environments. The company's core product is a polymer designed for integration into plastics, paints, and coatings. This technology enables surfaces to absorb and slowly release biocides, effectively reducing microorganism populations and hazardous pathogens like viruses, Listeria monocytogenes, Salmonella, and Campylobacter. Bio Fence serves markets in Israel, Europe, and North America, operating within the Industrial Technologies sector, with applications in industries such as food and beverage, healthcare, and public safety.

Strategic signal

In February 2021, Bio Fence raised $3.8 million in capital for its disinfectant technology. This funding validates the market's interest in advanced antimicrobial solutions and positions Bio Fence to further develop and commercialize its polymer-based coating, signaling potential for broader adoption in public health and industrial applications.

Company Intelligence Q&A

What is Bio Fence's primary focus?

Bio Fence focuses on developing antiviral and antimicrobial surface coatings to reduce infections caused by contaminated environments.

When was Bio Fence founded?

Bio Fence was founded in November 2017.

How much capital has Bio Fence raised?

Bio Fence has raised $4.5 million in total funding.

Which investor led Bio Fence's A Round?

In February 2021, Clean Value Ventures led Bio Fence's A Round of funding, which raised $3.8 million for its disinfectant technology.

What was a significant product development announced by Bio-Fence?

In January 2019, Bio-Fence announced a breakthrough in food safety with its antimicrobial coating technology.